“I hope that there is an equality of supply of vaccinations because we risk having, and in part it is already happening, Regions that are more sensitive to the issue, with more technical and economic resources, which make innovative proposals, and other Regions that instead lag behind” . It is a reference to the case of the vaccine against respiratory syncytial virus (RSV) that he did Carlo Signorelli,
president of Nitag – National immunization technical advisory group, on the occasion of the ninth edition of Long-Term Care, on the sidelines of the General States of active aging, underway in Rome.
“At this moment – he explains – the National Vaccination Prevention Plan 2023/2025 is in force which would provide for the possibility of updating the vaccination calendar”. Currently, the expert recalls, “the vaccinations offered are represented by the influenza vaccine, the anti-pneumococcal vaccine, the anti-Zoster vaccine and the Covid booster in the interested categories which are largely the elderly and frail subjects. The update is possible of course. Each vaccine that enters the calendar becomes an essential level in the national system. Therefore the technical part can express proposals, but then the scrutiny of the Ministry of Economy and Finance is necessary, which evaluates every intervention that determines a new expense. , a discussion which also applies to vaccination against the respiratory syncytial virus. In reality, it is one of the vaccines that is being discussed a lot, but which is still off the calendar at the moment. Only the Regions that have additional economic resources could theoretically administer it.” . “Some Regions, after having activated themselves for the vaccination of children, are thinking about it, especially for the elderly and the frail”, concludes Signorelli.
#Vaccines #Signorelli #Nitag #Equality #supply #syncytial #virus